An update on allergen immunotherapy and asthma

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Current opinion in pulmonary medicine

• Publication date

  2014-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MCP.0000000000000016PMID 24296688
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sublingual Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and Asthma: A Systematic Review

  2013cited by this paper
• Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.

  2013cited by this paper
• Allergen-Specific Immunotherapy for Pediatric Asthma and Rhinoconjunctivitis: A Systematic Review

  2013cited by this paper
• Efficacy of sublingual specific immunotherapy on allergic asthma and rhinitis in children's real life.

  2013cited by this paper
• Bronchial allergen provocation: A useful method to assess the efficacy of specific immunotherapy in children

  2013cited by this paper
• Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review

  2013cited by this paper
• Factors influencing the response to specific immunotherapy for asthma in children aged 5–16 years

  2013influential reference
• The contribution of sublingual immunotherapy to the achievement of control in birch-related mild persistent asthma: a real-life randomised trial.

  2013cited by this paper
• Medical Management and Sublingual Immunotherapy Practices in Patients with House Dust Mite-Induced Respiratory Allergy: A Retrospective, Observational Study

  2012cited by this paper
• Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile

  2012cited by this paper
• Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy.

  2012cited by this paper
• Mechanisms of allergen-specific immunotherapy

  2012cited by this paper
• High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study.

  2012cited by this paper
• Comparative effect of pre‐coseasonal and continuous grass sublingual immunotherapy in children

  2012cited by this paper
• [Efficacy of specific sublingual immunotherapy with dermatophagoides farinae drops in the treatment of cough variant asthma in children].

  2012influential reference
• The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: a Global Allergy and Asthma European Network (GA(2)LEN) article.

  2011cited by this paper
• Sublingual immunotherapy in allergic rhinitis

  2011cited by this paper
• Tolerability and efficacy of house dust mite AIT

  2011cited by this paper
• Effect of One-Year Subcutaneous and Sublingual Immunotherapy on Clinical and Laboratory Parameters in Children with Rhinitis and Asthma: A Randomized, Placebo-Controlled, Double-Blind, Double-Dummy Study

  2011cited by this paper
• Sublingual immunotherapy for allergic rhinitis.

  2010cited by this paper
• Observational Study of the Safety of an Ultra-Rush Sublingual Immunotherapy Regimen to Treat Rhinitis due to House Dust Mites

  2010cited by this paper
• Injection allergen immunotherapy for asthma.

  2010cited by this paper
• Steroid-sparing effects with allergen-specific immunotherapy in children with asthma: a randomized controlled trial.

  2010cited by this paper
• [Allergic rhinitis and its impact on asthma].

  2010cited by this paper
• Safety of ultra‐rush titration of sublingual immunotherapy in asthmatic children with tree‐pollen allergy

  2010cited by this paper
• Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen.

  2009cited by this paper
• Sub-Lingual Immunotherapy

  2009cited by this paper
• Mechanisms of Sublingual Immunotherapy

  2009cited by this paper
• Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy.

  2009cited by this paper
• Sublingual immunotherapy for allergic respiratory diseases: an evaluation of meta-analyses.

  2009cited by this paper
• Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies

  2009cited by this paper
• Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses.

  2009cited by this paper
• Immune tolerance in allergy.

  2009cited by this paper
• Efficacy and safety of high‐doses sublingual immunotherapy in ultra‐rush scheme in children allergic to grass pollen

  2009cited by this paper
• New visions in specific immunotherapy in children: an iPAC summary and future trends

  2008cited by this paper
• Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age.

  2008cited by this paper
• Expression of smooth muscle and extracellular matrix proteins in relation to airway function in asthma.

  2008cited by this paper
• Mechanisms of allergen-specific immunotherapy.

  2007cited by this paper
• Assessment of sublingual immunotherapy efficacy in children with house dust mite‐induced allergic asthma optimally controlled by pharmacologic treatment and mite‐avoidance measures

  2007cited by this paper
• Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce

  2007cited by this paper
• Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA2LEN

  2007cited by this paper
• Allergen immunotherapy: a practice parameter third update.

  2007cited by this paper
• Efficacy of long‐term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite‐allergic children with asthma

  2007cited by this paper
• Specific immunotherapy has long‐term preventive effect of seasonal and perennial asthma: 10‐year follow‐up on the PAT study

  2007cited by this paper
• Efficacy of sublingual immunotherapy in asthma: systematic review of randomized‐clinical trials using the Cochrane Collaboration method

  2006cited by this paper
• Sublingual immunotherapy: update 2006

  2006cited by this paper
• Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double‐blind, randomized, placebo‐controlled study

  2006cited by this paper
• Five‐year follow‐up on the PAT study: specific immunotherapy and long‐term prevention of asthma in children

  2006cited by this paper
• Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials.

  2006cited by this paper
• Long-term inhaled corticosteroids in preschool children at high risk for asthma.

  2006cited by this paper
• Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.

  2006cited by this paper
• Steroid‐sparing effect of subcutaneous SQ‐standardised specific immunotherapy in moderate and severe house dust mite allergic asthmatics

  2006cited by this paper
• Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis

  2006cited by this paper
• Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.

  2004cited by this paper
• Sublingual immunotherapy: an update

  2004cited by this paper
• Grading quality of evidence and strength of recommendations

  2004cited by this paper
• Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.

  2004cited by this paper
• Effect of specific immunotherapy added to pharmacologic treatment and allergen avoidance in asthmatic patients allergic to house dust mite.

  2004cited by this paper
• Long‐lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10‐year prospective study

  2003cited by this paper
• Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy.

  2003cited by this paper
• Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate

  2003cited by this paper
• Allergic rhinitis and its impact on asthma.

  2001cited by this paper
• Clinical and immunologic effects of long‐term sublingual immunotherapy in asthmatic children sensitized to mites:a double‐blind, placebo‐controlled study

  2000cited by this paper
• . . . and clinical immunology?

  2000cited by this paper
• Immunotherapy in children with allergic asthma: effect on bronchial hyperreactivity and pharmacotherapy.

  1999cited by this paper
• Sublingual‐swallow immunotherapy (SLIT) in patients with asthma due to house‐dust mites: a double‐blind, placebo‐controlled study

  1999cited by this paper
• Immunotherapy vs inhaled budesonide in bronchial asthma: an open, parallel comparative trial

  1998cited by this paper
• A controlled trial of immunotherapy for asthma in allergic children.

  1997cited by this paper
• Immunotherapy vs inhaled budesonide in bronchial asthma: an open, parallel, comparative trial

  1997cited by this paper
• Effects of immunotherapy on symptoms, PEFR, spirometry, and airway responsiveness in patients with allergic asthma to house‐dust mites (D. pteronyssinus) on inhaled steroid therapy

  1996cited by this paper
• GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION

  1996cited by this paper
• Survey of fatalities from skin testing and immunotherapy 1985-1989.

  1993cited by this paper
• Position Paper: Immunotherapy

  1993cited by this paper
• Fatalities from immunotherapy (IT) and skin testing (ST)

  1987cited by this paper
• VACCINATION AGAINST HAY FEVER: REPORT OF RESULTS DURING THE LAST THREE YEARS.

  1914cited by this paper

• Evolution Of Immunotherapy Against Pollen Allergy.

  2023cites this paper
• Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper

  2023cites this paper
• Grand Rounds Review Article: "Allergen immunotherapy for asthma".

  2023cites this paper
• Stimulation of naïve B cells with a fusion protein consisting of FlaA and Bet v 1 induces regulatory B cells ex vivo

  2022cites this paper
• Role of periostin in evaluating the responsiveness of allergic patients to allergen-specific immunotherapy

  2022cites this paper
• Difficult and Severe Asthma in Children

  2020cites this paper
• Bioinformatics-Based Research on Key Genes and Pathways of Intervertebral Disc Degeneration

  2020cites this paper
• Allergen Immunotherapy in Pediatric Asthma: A Pragmatic Point of View

  2020cites this paper
• Nasal allergen‐neutralizing IgG4 antibodies block IgE‐mediated responses: Novel biomarker of subcutaneous grass pollen immunotherapy

  2019cites this paper
• The growing importance of real-life studies in allergen immunotherapy

  2019cites this paper
• Modern Molecular Therapies for Application in Managing Childhood Asthma

  2019cites this paper
• Clinical efficacy of implementing Bio Immune(G)ene MEDicine in the treatment of chronic asthma with the objective of reducing or removing effectively corticosteroid therapy: A novel approach and promising results.

  2018cites this paper
• Immunotherapy and Asthma in Children

  2018cites this paper
• Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper

  2017cites this paper
• Update on Biomarkers to Monitor Clinical Efficacy Response During and Post Treatment in Allergen Immunotherapy

  2017cites this paper
• Quality-of-Life Outcomes in Patients who Underwent Subcutaneous Immunotherapy and Sublingual Immunotherapy in a Real-World Clinical Setting

  2017cites this paper
• Curcumin reduces lung inflammation via Wnt/β-catenin signaling in mouse model of asthma

  2017cites this paper
• Polarization of Helper T Lymphocytes Maybe Involved in the Pathogenesis of Lumbar Disc Herniation.

  2017cites this paper
• Applications and mechanisms of immunotherapy in allergic rhinitis and asthma

  2017cites this paper
• CD80 and CD86 knockdown in dendritic cells regulates Th1/Th2 cytokine production in asthmatic mice.

  2016cites this paper
• Clinical Efficacy of Immunotherapy in Allergic Rhinitis

  2016cites this paper
• Update on immunotherapy for the treatment of asthma

  2016cites this paper
• Regulation of Th1/Th2 balance through OX40/OX40L signalling by glycyrrhizic acid in a murine model of asthma

  2016cites this paper
• Changes in T cell subpopulations after specific sublingual immunotherapy against Dermatophagoides farinae

  2016cites this paper
• T Cell Epitope Peptide Therapy for Allergic Diseases

  2016cites this paper
• Induction of Bronchial Tolerance After 1 Cycle of Monophosphoryl-A-Adjuvanted Specific Immunotherapy in Children With Grass Pollen Allergies

  2016cites this paper
• Clinical contraindications to allergen immunotherapy: an EAACI position paper

  2015cites this paper
• Current developments for improving efficacy of allergy vaccines

  2015cites this paper
• New Targets for Immune Modulation in Asthma

  2014cites this paper
• Drug-Related Genomics in Cancer and Immunological Diseases

  2014cites this paper
• Immunotherapy in allergy and cellular tests

  2014cites this paper
• The nasal airway in asthmatics-from a structural, functional and subjective perspective

  2014cites this paper
• In Silico Prediction of T and B Cell Epitopes of Der f 25 in Dermatophagoides farinae

  2014cites this paper
• Scientific foundations of allergen-specific immunotherapy for allergic disease.

  2014cites this paper
• Immunotherapy Reduces Allergen-Mediated CD66b Expression and Myeloperoxidase Levels on Human Neutrophils from Allergic Patients

  2014cites this paper